Day 4 of impeachment hearings

Study shows new treatment helps preserve fertility during chemo

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Young breast cancer patients are often faced with the difficult decision of choosing a treatment that will kill their cancer.

As a result, the treatment could also kill their ability to get pregnant.

Now a new study suggests giving women a drug that quiets their ovaries during chemotherapy.

According to the study, the drug Goserelin may preserve a woman’s fertility during chemo.

Sharon Giodano, a Professor of Medicine at MD Anderson Cancer Center said, “It essentially shuts down ovarian activity while the patients are on chemotherapy.”

More than 100 women participated in the study.

Researchers found those given the drug were less likely to experience ovarian failure and more likely to get pregnant after chemo.

There were 16 healthy pregnancies among the women given Goserlin, compared to seven among those not treated.

Giordano said, “It is an exciting study because it does add another option for our young breast cancer patients, and even though the data we have isn’t perfect, at least it gives us some evidence that there’s something you can do to help preserve your fertility.”

The study only looked at women with estrogen receptor negative breast cancer.

Many of the participants had what is called “triple negative” breast cancer.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.